Your browser doesn't support javascript.
loading
cPLA2α reversibly regulates different subsets of cancer stem cells transformation in cervical cancer.
He, Yuchao; Xiao, Manyu; Fu, Hui; Chen, Lu; Qi, Lisha; Liu, Dongming; Guo, Piao; Chen, Liwei; Luo, Yi; Xiao, Huiting; Zhang, Ning; Guo, Hua.
Afiliação
  • He Y; Department of Tumor Cell Biology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Xiao M; Department of Tumor Cell Biology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Fu H; Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
  • Chen L; Department of Hepatobiliary Tumor, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Qi L; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, People's Republic of China.
  • Liu D; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, People's Republic of China.
  • Guo P; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Chen L; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, People's Republic of China.
  • Luo Y; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Xiao H; Department of Tumor Cell Biology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Zhang N; Department of Tumor Cell Biology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Guo H; Department of Tumor Cell Biology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
Stem Cells ; 38(4): 487-503, 2020 04.
Article em En | MEDLINE | ID: mdl-32100928
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Fosfolipases A2 do Grupo IV Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Fosfolipases A2 do Grupo IV Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article